期刊文献+

Both APRI and FIB‐4 could effectively evaluate liver fibrosis in liver transplantation recipients

原文传递
导出
摘要 To the Editor,Liver transplantation(LT)is the only curative therapy for patients with end‐stage liver disease.1 Due to the high incidence of metabolic syndrome after LT,nonalcoholic fatty liver disease(NAFLD)has gradually become an essential cause of post‐LT fibrosis.2 Liver fibrosis can progress to liver cirrhosis and carries the risk of developing hepatocellular carcinoma(HCC),which adversely affects long‐term survival after LT.3,4 Early detection and active intervention for liver fibrosis after LT are crucial in LT recipients.Previous studies have confirmed that transient elastography(TE)could accurately detect liver fibrosis in LT recipients by comparing TE with liver biopsy.
出处 《Portal Hypertension & Cirrhosis》 2022年第3期197-199,共3页 门静脉高压与肝硬化(英文)
关键词 liver CURATIVE NAFLD
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部